Clinical Trials Directory

Trials / Completed

CompletedNCT02037880

Natural History Studies of Mucopolysaccharidosis III

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess rates of decline in motor and cognitive functional measures, and to assess potential biomarkers, in order to identify potential outcome measure appropriate for use in therapeutic clinical trials.

Detailed description

Mucopolysaccharidosis (MPS) type III (Sanfilippo syndrome) is a group of four devastating genetic diseases that result in the abnormal accumulation of glycosaminoglycans in body tissues. In MPSIII the predominant symptoms occur due to accumulation within the central nervous system (CNS), including the brain and spinal cord, resulting in cognitive decline, motor dysfunction, and eventual death. In anticipation for future therapeutic studies for MPSIIIA and MPSIIIB, we are performing a natural history study to identify the following: 1. Individual rates of decline in motor and cognitive function in a cohort of potential clinical trial patients 2. The natural history of outcome measures in order to assess their appropriateness as outcomes in an eventual trial 3. Baseline functional data in patients who will be potential candidates for an eventual trial 4. Biomarkers of disease progression over a 12-month interval, including changes in brain MRI and in cerebrospinal fluid Patients in this study will need to come to Nationwide Children's Hospital in Columbus, Ohio, three times. At each of these three time points, cognitive outcome measures will be assessed: at baseline (visit 1), 6 months (visit 2), and at 12 months (visit 3). At baseline (visit 1) and 12 months (visit 3), an MRI and a lumbar puncture will be performed.

Conditions

Interventions

TypeNameDescription
PROCEDURELumbar puncture
DEVICEMagnetic Resonance Imaging (MRI) of the brain

Timeline

Start date
2014-02-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2014-01-16
Last updated
2015-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02037880. Inclusion in this directory is not an endorsement.